170 material Form 8-K filings that 150 companies we cover made with the SEC in September 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Voya Financial completed a registered public offering of $400 million of 5.000% Senior Notes due 2034 on September 20, 2024, with aggregate net proceeds of approximately $396.0 million. The company intends to use the proceeds for general corporate purposes, which may include repaying its $400 million 3.976% Senior Notes maturing February 15, 2025.
Notes: $400 million principal, 5.000% interest, maturing September 20, 2034
Net proceeds to Voya of approximately $396.0 million after commissions and estimated expenses
Interest payable March 20 and September 20 each year, starting March 20, 2025
Proceeds may repay $400 million of 3.976% Senior Notes due February 15, 2025
Balchem Corporation rebalanced its board by having four directors resign from one class and get immediately re-elected to another, effective September 20, 2024, so each class has about one-third of the directors. The board also adopted a Maryland provision under which board vacancies may be filled only by a majority of the remaining directors, a change that affects how future board seats are filled.
Daniel Knutson and Joyce Lee moved from Class 2 to Class 3 effective September 20, 2024.
Monica Vicente moved from Class 2 to Class 1, and Kathleen Fish moved from Class 1 to Class 2.
The board adopted the Maryland vacancy provision on September 18, 2024, and filed Articles Supplementary on September 19, 2024.
The filing states the reclassification was solely for rebalancing and that each director's service is deemed uninterrupted.
Box, Inc. sold $400 million of 1.50% Convertible Senior Notes due 2029, and initial purchasers exercised their option in full on September 18, 2024, raising the total to $460 million. The company used part of the proceeds to repurchase $140.0 million of its 0% Convertible Senior Notes due 2026, which adds new debt while reducing older convertible debt.
Notes bear 1.50% interest and mature September 15, 2029; the notes are convertible at an initial price of about $43.46 per share, a premium of about 30% to the $33.43 closing price on September 17, 2024.
Net proceeds were about $447.8 million after discounts and expenses; about $52.5 million went to capped call transactions and about $191.7 million to repurchase $140.0 million of 2026 Notes.
The company may not redeem the notes before September 20, 2027, and holders can require repurchase at 100% of principal upon a fundamental change.
Otis Worldwide has entered into an amended and restated employment agreement with Cristina Méndez, who was appointed Executive Vice President and Chief Financial Officer effective August 23, 2024. The filing sets out her base salary, incentive targets, a supplemental equity award and an international relocation to the company's Connecticut headquarters.
Annual base salary of $770,000 with a short-term incentive target equal to 100% of salary
Supplemental 2024 long-term incentive award with an aggregate target value of $2,390,000, granted August 23, 2024
Relocation from Switzerland to Farmington, Connecticut, with a $5,000 monthly housing allowance and a one-time relocation allowance of 12,792 CHF
Covered by the ELG Severance Plan and Change in Control Severance Plan, with a 2-year post-employment noncompetition covenant
Director Daniel N. Swisher Jr., a member of the Audit Committee, resigned from Protagonist Therapeutics' board effective September 17, 2024, and will continue as an advisor under an advisory agreement. The filing says he did not report any disagreement with the company, and the board was reduced from seven seats to six, with Sarah A. O'Dowd added to the Audit Committee effective September 19, 2024.
Daniel N. Swisher Jr. resigned from the Board effective September 17, 2024, and was an Audit Committee member
Swisher will continue to serve as an advisor under an advisory agreement
Sarah A. O'Dowd was appointed to the Audit Committee effective September 19, 2024
Citizens Financial Group named Claude E. Wade, an AIG executive vice president and Chief Digital Officer, as a director effective March 1, 2025, temporarily expanding the board to 14 members. Director Wendy Watson, who has served since 2010 and chairs the Audit Committee, will retire after her term expires at the April 2025 annual shareholder meeting because she reached the mandatory retirement age.
Claude E. Wade joins the board effective March 1, 2025 and will serve on the Risk Committee
Wade is executive vice president, Chief Digital Officer and Global Head of Business Operations and Global Head of Claims at AIG; he joined AIG in 2021 after BlackRock
Wendy Watson, a director since 2010 and Audit Committee chair, will retire after her term expires at the April 2025 annual meeting
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.